261 related articles for article (PubMed ID: 10999736)
1. Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.
Connolly DC; Greenspan DL; Wu R; Ren X; Dunn RL; Shah KV; Jones RW; Bosch FX; Muñoz N; Cho KR
Clin Cancer Res; 2000 Sep; 6(9):3505-10. PubMed ID: 10999736
[TBL] [Abstract][Full Text] [Related]
2. Reduced Fhit expression in cervical carcinoma: correlation with tumor progression and poor prognosis.
Huang LW; Chao SL; Chen TJ
Gynecol Oncol; 2003 Aug; 90(2):331-7. PubMed ID: 12893195
[TBL] [Abstract][Full Text] [Related]
3. FHIT (fragile histidine triad) gene analysis in cervical intraepithelial neoplasia.
Liu FS; Hsieh YT; Chen JT; Ho ES; Hung MJ; Lin AJ
Gynecol Oncol; 2001 Aug; 82(2):283-90. PubMed ID: 11531281
[TBL] [Abstract][Full Text] [Related]
4. FHIT alterations in cancerous and non-cancerous cervical epithelium.
Yoshino K; Enomoto T; Nakamura T; Sun H; Ozaki K; Nakashima R; Wada H; Saitoh J; Watanabe Y; Noda K; Murata Y
Int J Cancer; 2000 Jan; 85(1):6-13. PubMed ID: 10585575
[TBL] [Abstract][Full Text] [Related]
5. Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer.
Butler D; Collins C; Mabruk M; Leader MB; Kay EW
Gynecol Oncol; 2002 Aug; 86(2):144-9. PubMed ID: 12144820
[TBL] [Abstract][Full Text] [Related]
6. Laminin-5 gamma 2 chain expression in cervical intraepithelial neoplasia and invasive cervical carcinoma.
Noel JC; Fernandez-Aguilar S; Fayt I; Buxant F; Ansion MH; Simon P; Anaf V
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1119-23. PubMed ID: 16232183
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Fhit expression in malignant and premalignant lesions of the cervix.
Birrer MJ; Hendricks D; Farley J; Sundborg MJ; Bonome T; Walts MJ; Geradts J
Cancer Res; 1999 Oct; 59(20):5270-4. PubMed ID: 10537308
[TBL] [Abstract][Full Text] [Related]
8. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the reduction of FHIT expression and the development of cervical carcinoma].
Liu H; Peng ZL; Yang KX; Liu SL; Wang H; Zhang CS; Fan YJ; Zheng A
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):846-8. PubMed ID: 15573771
[TBL] [Abstract][Full Text] [Related]
10. MAD2 and CDC20 are upregulated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix.
Kim Y; Choi JW; Lee JH; Kim YS
Int J Gynecol Pathol; 2014 Sep; 33(5):517-23. PubMed ID: 25083970
[TBL] [Abstract][Full Text] [Related]
11. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix.
Yoshino K; Enomoto T; Nakamura T; Nakashima R; Wada H; Saitoh J; Noda K; Murata Y
Int J Cancer; 1998 Apr; 76(2):176-81. PubMed ID: 9537577
[TBL] [Abstract][Full Text] [Related]
12. A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix.
Nakagawa S; Yoshikawa H; Kimura M; Kawana K; Matsumoto K; Onda T; Kino N; Yamada M; Yasugi T; Taketani Y
Br J Cancer; 1999 Feb; 79(3-4):589-94. PubMed ID: 10027335
[TBL] [Abstract][Full Text] [Related]
13. FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women.
Yang F; Cui Z; Liao Y; Tian R; Fan W; Jin Z; Hu Z; Yao S
Cancer Biomark; 2020; 27(3):303-312. PubMed ID: 31771040
[TBL] [Abstract][Full Text] [Related]
14. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
[TBL] [Abstract][Full Text] [Related]
15. Maspin expression in CIN 3, microinvasive squamous cell carcinoma, and invasive squamous cell carcinoma of the uterine cervix.
Xu C; Quddus MR; Sung CJ; Steinhoff MM; Zhang C; Lawrence WD
Mod Pathol; 2005 Aug; 18(8):1102-6. PubMed ID: 15731774
[TBL] [Abstract][Full Text] [Related]
16. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of apoptosis-related protein 3 is highly associated with tumorigenesis and progression of cervical squamous cell carcinoma.
Zhang Y; Li Q; Huang W; Zhang J; Han Z; Wei H; Cui J; Wang Y; Yan W
Hum Pathol; 2013 Mar; 44(3):388-93. PubMed ID: 23036366
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions.
Yoshida T; Sano T; Kanuma T; Owada N; Sakurai S; Fukuda T; Nakajima T
Cancer; 2008 Apr; 114(2):83-8. PubMed ID: 18300235
[TBL] [Abstract][Full Text] [Related]
19. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution.
Chu TY; Shen CY; Lee HS; Liu HS
Genes Chromosomes Cancer; 1999 Feb; 24(2):127-34. PubMed ID: 9885979
[TBL] [Abstract][Full Text] [Related]
20. [Interaction between abnormal expression of fragile histidine triad and methyl-CpG-binding protein 2 on cervical cancerization].
Yang Q; Li Y; Wang L; Song ZC; Feng MJ; Ding L; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):689-693. PubMed ID: 29860820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
